Zilong Wang

Zilong Wang

Auto-generated profile, based on publicly available information

Zilong Wang

Department of Burns and Plastic Surgery The Seventh Affiliated Hospital, Sun Yat‐sen University Shenzhen China

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 January 2021 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
CHChenglin Han
Chenglin Han
ZWZilong Wang
Zilong Wang
SCShuxiao Chen
Shuxiao Chen
LLLin Li
Lin Li
YXYingkun Xu
Yingkun Xu
XJXunbo Jin
Xunbo Jin
Berbamine (BBM), one of the bioactive ingredients extracted from Berberis plants, has attracted intensive attention because of its significant antitumor activity against various malignancies. However, the exact role and potential molecular mechanism of berbamine in bladder cancer (BCa) remain unclear. In the present study, our results showed that berbamine inhibited cell viability, colony formation, and proliferation. Additionally, berbamine induced cell cycle arrest at S phase by a synergistic mechanism involving stimulation of P21 and P27 protein expression as well as downregulation of CyclinD, CyclinA2, and CDK2 protein expression. In addition to suppressing epithelial‐mesenchymal transition (EMT), berbamine rearranged the cytoskeleton to inhibit cell metastasis. Mechanistically, the expression of P65, P‐P65, and P‐IκBα was decreased upon berbamine treatment, yet P65 overexpression abrogated the effects of berbamine on the proliferative and metastatic potential of BCa cells, which indicated that berbamine attenuated the malignant biological activities of BCa cells by inhibiting the NF‐κB pathway. More importantly, berbamine increased the intracellular reactive oxygen species (ROS) level through the downregulation of antioxidative genes such as Nrf2, HO‐1, SOD2, and GPX‐1. Following ROS accumulation, the intrinsic apoptotic pathway was triggered by an increase in the ratio of Bax/Bcl‐2. Furthermore, berbamine‐mediated ROS accumulation negatively regulated the NF‐κB pathway to a certain degree. Consistent with our in vitro results, berbamine successfully inhibited tumor growth and blocked the NF‐κB pathway in our xenograft model. To summarize, our data demonstrated that berbamine exerts antitumor effects via the ROS/NF‐κB signaling axis in bladder cancer, which provides a basis for further comprehensive study and presents a potential candidate for clinical treatment strategies against bladder cancer.

20 December 2024 in Molecular Cancer
Verified
Journal Article
Open access
PDF file
ZWZilong Wang
Zilong Wang
JYJiaying Yu
Jiaying Yu
WZWenli Zhu
Wenli Zhu
XHXiaoning Hong
Xiaoning Hong
ZXZhen Xu
Zhen Xu
XXXiang Xi
Xiang Xi
Extrachromosomal circular DNAs (eccDNAs) are a type of circular DNAs originating from but independent of chromosomal DNAs. Nowadays, with the rapid development of sequencing and bioinformatics, the accuracy of eccDNAs detection has significantly improved. This advancement has consequently enhanced the feasibility of exploring the biological characteristics and functions of eccDNAs. This review elucidates the potential mechanisms of eccDNA generation, the existing methods for their detection and analysis, and their basic features. Furthermore, it focuses on the biological functions of eccDNAs in regulating gene expression under both physiological and pathological conditions. Additionally, the review summarizes the clinical implications of eccDNAs in human cancers and health.

1 March 2021 in OncoTargets and Therapy
Verified
Journal Article
Open access
PDF file
CHChenglin Han
Chenglin Han
SCShuxiao Chen
Shuxiao Chen
HMHaiyang Ma
Haiyang Ma
XWXiangchuan Wen
Xiangchuan Wen
ZWZilong Wang
Zilong Wang
MWMuwen Wang
Muwen Wang
Background: Ribophorin II (RPN2) is a highly conserved glycoprotein involved in the N-linked glycosylation of multiple proteins. RPN2 was reported to be associated with malignant phenotype in several tumors. However, the function of RPN2 in bladder cancer (BCa) remains unclear. Methods: Expression of RPN2 in BCa and adjacent tissues was compared by bioinformatics analysis, immunohistochemistry, and Western blotting. qRT-PCR was performed to explore the correlation between RPN2 expression and various clinical features in 38 patients. We assessed the effects of RPN2 on the biological activity of BCa both in vitro and in vivo, and explored its potential mechanisms based on gene set enrichment analysis (GSEA). Results: We found that RPN2 was highly expressed in human BCa compared with normal adjacent tissues. There was a significant positive correlation between higher RPN2 mRNA levels and tumor T stage, lymph node (LN) metastasis and the degree of pathological differentiation in 38 patients with BCa. We further demonstrated that RPN2 silencing inhibited the growth and metastasis of BCa both in vitro and in vivo. Western blotting revealed that RPN2 knockdown suppressed epithelial-mesenchymal transition (EMT) and inhibited the PI3K-Akt pathway. Conclusion: These data suggest that RPN2 functions as an oncogene to promote tumor development and is a promising prognostic factor and therapeutic target in BCa.

30 December 2020 in Journal of Oncology
Verified
Journal Article
Open access
PDF file
GWGuangzhen Wu
Guangzhen Wu
YXYingkun Xu
Yingkun Xu
CHChenglin Han
Chenglin Han
ZWZilong Wang
Zilong Wang
JLJiayi Li
Jiayi Li
XCXiangyu Che
Xiangyu Che
Purpose. To construct a survival model for predicting the prognosis of patients with kidney renal clear cell carcinoma (KIRC) based on gene expression related to immune response regulation. Materials and Methods. KIRC mRNA sequencing data and patient clinical data were downloaded from the TCGA database. The pathways and genes involved in the regulation of the immune response were identified from the GSEA database. A single factor Cox analysis was used to determine the association of mRNA in relation to patient prognosis . The prognostic risk model was further established using the LASSO regression curve. The survival prognosis model was constructed, and the sensitivity and specificity of the model were evaluated using the ROC curve. Results. Compared with normal kidney tissues, there were 28 dysregulated mRNA expressions in KIRC tissues . Univariate Cox regression analysis revealed that 12 mRNAs were related to the prognosis of patients with renal cell carcinoma. The LASSO regression curve drew a risk signature consisting of six genes: TRAF6, FYN, IKBKG, LAT2, C2, IL4, EREG, TRAF2, and IL12A. The five-year ROC area analysis (AUC) showed that the model has good sensitivity and specificity (AUC >0.712). Conclusion. We constructed a risk prediction model based on the regulated immune response-related genes, which can effectively predict the survival of patients with KIRC.

1 March 2014 in Journal of Asia-Pacific Entomology
Verified
Journal Article
Closed access
Xiaobo WuXiaobo Wu
Xiaobo Wu
ZWZilong Wang
Zilong Wang
FZFei Zhang
Fei Zhang
YSYuanyuan Shi
Yuanyuan Shi
ZZZhijiang Zeng
Zhijiang Zeng

26 May 2025 in Food Science & Nutrition
Verified
Journal Article
Open access
ZWZilong Wang
Zilong Wang
ZXZhen Xu
Zhen Xu
MLMeilu Li
Meilu Li
ZLZhenghao Li
Zhenghao Li
DLDan dan Li
Dan dan Li
XWXiaobin Wang
Xiaobin Wang
Erectile dysfunction (ED) is a prevalent condition severely impacting men's quality of life. While micronutrient balance is critical for sexual health, observational studies on micronutrient and ED remain inconclusive. The objective of this study was to evaluate the causal role of circulating levels of copper and other micronutrients in ED risk by Mendelian randomization (MR). We conducted bidirectional two‐sample MR using summary statistics from European‐ancestry cohorts involving thirteen micronutrients. Inverse‐variance weighted (IVW) MR was complemented by sensitivity analyses, including MR‐Egger and MR‐PRESSO, and pooled analysis of two GWAS‐based datasets was performed to substantiate the findings of MR. In this study, circulating copper levels significantly increased ED risk in the discovery (OR = 1.129, 95% CI: 1.004–1.27, p = 0.042) and replication (OR = 1.115, 95% CI: 1.001–1.242, p = 0.0476) stages, as well as pooled analyses (OR = 1.122, 95% CI: 1.036–1.214, p = 0.0046). Sensitivity analyses reinforced the robustness of these findings, with no significant heterogeneity or directional pleiotropy observed. Reverse MR found no causal effect of ED on micronutrients. In summary, this study provides robust genetic evidence that elevated circulating copper levels are a modifiable risk factor for ED. Personalized management of copper intake, guided by genetic predisposition, may mitigate ED risk and improve sexual health outcomes. These findings highlight the clinical relevance of copper homeostasis in ED prevention and underscore the need for targeted nutritional interventions.